This application is in response to a program announcement for high-risk/high-impact research. The objective of the proposed research is to determine whether nicotinic adenine dinucleotide phosphate (NAADP) is a mediator of calcium mobilization in mammalian systems. NAADP is a metabolite of beta- nicotinamide adenine dinucleotide 2'-phosphate (beta-NADP) that has been found to mobilize calcium from intracellular stores in sea urchin eggs. This occurs by a mechanism distinct from those mediated by IP3 or cyclic ADP-ribose. NAADP signaling has not been demonstrated in mammalian cells, although the enzymes necessary to synthesize and degrade NAADP are present and preliminary data suggests that NAADP may occur in mammalian cells. The following specific aims address the question of whether NAADP signaling is operational in mammalian cells. 1) Does NAADP occur in mammalian cells? 2) Are NAADP binding proteins detectable in mammalian cells? 3) Can NAADP induce calcium release in mammalian systems? These studies propose to identify a new Ca signaling pathway in mammalian cells, with important implications for our understanding of calcium ion mobilization.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21GM058492-01
Application #
2727917
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1999-02-01
Project End
2001-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pharmacology
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455